ABABioBlurb (@ABABioBlurb) profile picture

Official Twitter handle for the American Bar Association SciTech BioBlurb! Follow for updates on Biotech Law, Policy, and Markets!

Joined January 2014
IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed https://teapaw.org/t.co/45fLaymPei
Developing Products for Rare Diseases & Conditions https://teapaw.org/t.co/fL6ZrzJpIX
Drug Alerts and Statements https://teapaw.org/t.co/GMkaYGPmfQ
FDA to Hold Public Hearing May 31 Regarding Cannabis https://teapaw.org/t.co/SnmLl6bVpp
TeraPharm - 111111 - 10/09/2018 https://teapaw.org/t.co/4zOJKWgoMN
SUPAC: Manufacturing Equipment Addendum https://teapaw.org/t.co/3DHGpjcmYl
Botanical Drug Development: Guidance for Industry https://teapaw.org/t.co/IkwtECaLpd
Comparability Protocols for Human Drugs and Biologics: Chemistry, Manufacturing, and Controls Information Guidance for Industry https://teapaw.org/t.co/0BKH58YLfP
ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers https://teapaw.org/t.co/gnuUNyWoc0
Use of Liquids and/or Soft Foods as Vehicles for Drug Administration: General Considerations for Selection and In Vitro Methods for Product Quality Assessments https://teapaw.org/t.co/PIqgJDcyYm
Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products https://teapaw.org/t.co/fsOrx1Gqwq
Completeness Assessments for Type II API DMFs Under GDUFA Guidance for Industry https://teapaw.org/t.co/n6cdARon0j
Bispecific Antibody Development Programs Guidance for Industry https://teapaw.org/t.co/1G2AmDbiW6
Development and Submission of Near Infrared Analytical Procedures https://teapaw.org/t.co/fJp9MciRXF
Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules https://teapaw.org/t.co/sovzgB27nr
Regulatory Classification of Pharmaceutical Co-Crystals https://teapaw.org/t.co/5e1TKXYU9r
Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products--Quality Considerations https://teapaw.org/t.co/ywKWV7mQ1o
Immunogenicity-Related Considerations for Low Molecular Weight Heparin Guidance for Industry https://teapaw.org/t.co/UdmbiBmnUo
Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation https://teapaw.org/t.co/zNeBYEzzXc
Elemental Impurities in Drug Products Guidance for Industry https://teapaw.org/t.co/DFW95etAVo